Instil Bio, Inc.

TIL Healthcare Biotechnology

EPS
+80.6%
Free cash flow
+68.6%
Total debt
+0.91%

Quarter to June 2026, against a year earlier

6.85 0.14 −2.00%
Market cap
$47.4M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
— — — —

+8 more quarters

EV/Sales
— — — —
EV/FCF
— — — —
Current Ratio
21.67 39.87 39.53 34.45
Net Debt/EBITDA
(2.86) (1.47) (0.89) (0.31)
Debt/Equity
0.79 0.77 0.74 0.70
Free Cash Flow Yield
— — — —
Free Cash Flow per Share
(0.68) (0.20) (1.06) (1.56)
Book value per Share
15.83 16.32 17.08 17.82
Free Cash Flow
(4.64) (1.34) (7.08) (10.56)
Other line items

Show all line items

Columns are period end dates